Omega Diagnostics (UK) upgrades tuberculosis kit for Indian market:
This article was originally published in Clinica
Executive Summary
Omega Diagnostics (UK) is increasing the sensitivity of its TB ELISA. The privately-held Scottish company is making the improvements - to aid in the diagnosis of difficult cases such as sputum-negative/TB-positive and extrapulmonary disease - at the request of the Indian Council of Medical Research (a government body). Omega hopes to secure development funding from the Scottish Office of the UK government and says an application for WHO trial funding is under review. The work is expected to take about a year. Omega already sells the kit throughout the Indian subcontinent around the Pacific Rim.